Engineered Regeneration


The Engineered Regeneration is an open access journal publishes research related to regenerative medicine, tissue engineering, biofabrication, biomaterials, drug delivery, disease treatment. The ISSN of the journal is , 2666-1381. Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Engineered Regeneration: Details

Journal TitleEngineered Regeneration
PublisherKeAi Communications Co., Ltd.
Publication CountryChina
eISSN2666-1381
Publication AreaScience: Biology (General): Life
Publication LanguageEnglish
Review ProcessAnonymous peer review
Publication Time7 weeks
Scopus IndexedYes

Publication Fee

There is a fee to publish in the Engineered Regeneration. The publication fee is 840 USD.

Journal Official Website

The official website of the journal is http://www.keaipublishing.com/en/journals/engineered-regeneration/. Please visit only official website of the journal to submit research papers.

Similiar journals to publish


Engineered Regeneration
ISSN: 2666-1381
Publisher: KeAi Communications Co., Ltd.
Journal Scope: regenerative medicine, tissue engineering, biofabrication, biomaterials, drug delivery, disease treatment

Journal of Engineered Fibers and Fabrics
ISSN: 1558-9250
Publisher: SAGE Publishing
Journal Scope: textile engineering, textile life cycle, fibre-based structures, fibrous structures, fabrics, fibre

Neural Regeneration Research
ISSN: 1876-7958
Publisher: Wolters Kluwer Medknow Publications
Journal Scope: neural regeneration, peripheral nerve injury, brain injury, spinal cord injury

Inflammation and Regeneration
ISSN: 1880-8190
Publisher: BMC
Journal Scope: regenerative medicine, inflammation

Cell Regeneration
ISSN: 2045-9769
Publisher: SpringerOpen
Journal Scope: stem cells, regenerative biology, tissue regeneration

Regeneration, Reconstruction & Restoration
ISSN: 2476-5171
Publisher: Shahid Beheshti University of Medical Sciences
Journal Scope: regeneration, reconstruction, restoration, craniomaxillofacial, mesenchymal stem cells